34662-36-7

Basic information

• Product Name: 3-chloro-5-nitro-benzoic acid
• Synonyms: 3-chloro-5-nitro-benzoic acid;3-Nitro-5-chlorobenzoic acid;3-Chloro-5-nitrobenzoic acid: 3-Nitro-5-chlorobenzoic acid
• CAS NO: 34662-36-7
• Molecular Formula: C₇H₄ClNO₄
• Molecular Weight: 201.57
• Mol File: 34662-36-7.mol

Chemical Properties

• Boiling Point: 351.1 °C at 760 mmHg
• Flash Point: 166.1 °C
• Appearance: /
• Density: 1.602 g/cm³
• Vapor Pressure: 1.56E-05mmHg at 25°C
• Refractive Index: 1.627
• Storage Temp.: Room temperature.
• PKA: 3.11±0.10(Predicted)
• CAS DataBase Reference: 3-chloro-5-nitro-benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-5-nitro-benzoic acid(34662-36-7)
• EPA Substance Registry System: 3-chloro-5-nitro-benzoic acid(34662-36-7)

Safety Data

• Hazardous Substances Data: 34662-36-7(Hazardous Substances Data)

Usage

Uses

3-Chloro-5-nitrobenzoic acid

InChI:InChI=1/C7H4ClNO4/c8-5-1-4(7(10)11)2-6(3-5)9(12)13/h1-3H,(H,10,11)

Upstream product

• 49709-31-1 2-chloro-5-nitro-3-ethylbenzene 
• 100-00-5 4-chlorobenzonitrile 
• 101084-81-5 (3-carboxy-5-nitrophenyl)boronic acid 
• 20352-84-5 1-amino-2-cyano-4-nitro-6-chlorobenzene 
• 34662-30-1 1-nitro-3-chloro-5-cyanobenzene 
• 618-84-8 3-amino-5-nitro-benzoic acid 
• 33098-65-6 2-acetamido-1-ethylbenzene 
• 6853-29-8 4-amino-3-ethyl-1-nitrobenzene 
• 578-54-1 ortho-ethylaniline 
• 69422-57-7 1-chloro-2-(chloromethyl)-4-nitrobenzene 
• 13290-74-9 1-chloro-2-methyl-4-nitrobenzene 
• 535-80-8 3-chlorobenzoate 

Downstream Products

• 36138-28-0 3-chloro-5-nitro-benzoic acid methyl ester 
• 1448812-14-3 N-(3-chloro-5-(((4-cyano-3-methyl-1-phenyl-1H-pyrazol-5-yl)amino)methyl)phenyl)propionamide 
• 1448812-11-0 3-chloro-5-propionamidobenzoic acid 
• 1448812-12-1 N-(3-chloro-5-(hydroxymethyl)phenyl)propionamide 
• 1448812-13-2 N-(3-chloro-5-formylphenyl)propionamide 
• 50826-02-3 3-Chlor-5-nitrobenzamid 
• 79944-62-0 (3-chloro-5-nitrophenyl)methanol 
• 145235-71-8 2-imino-3-(3-chloro-5-nitrobenzoylmethyl)thiazoline hydrobromide 
• 145235-75-2 6-(3-chloro-5-nitrophenyl)-2,3,5,6-tetrahydroimidazo<2,1-b>bthiazole 
• 145235-66-1 6-(3-amino-5-chlorophenyl)-2,3,5,6-tetrhydroimidazo<2,1-b>thiazole dihydrochloride 
• 145028-61-1 4-Chloro-N-[3-chloro-5-(2,3,5,6-tetrahydro-imidazo[2,1-b]thiazol-6-yl)-phenyl]-benzamide 
• 145028-81-5 3-[2-Chloro-2-(3-chloro-5-nitro-phenyl)-ethyl]-thiazolidin-2-ylideneamine 

Relevant articles and documents

The pyrazole derivative or its salt in a pharmaceutical composition containing them

PROBLEM TO BE SOLVED: To provide a novel compound and a pharmaceutical composition useful for treatment and/or prevention of HIV virus infections.SOLUTION: Provided is a pyrazole derivative represented by the general formula (I) or a salt thereof (in the

Structure-activity relationship study of phenylpyrazole derivatives as a novel class of anti-HIV agents

The structure-activity relationship of phenylpyrazole derivative 1 was investigated for the development of novel anti-HIV agents. Initial efforts revealed that the diazenyl group can be replaced by an aminomethylene group. In addition, we synthesized various derivatives by the reductive amination of benzaldehydes with 5-aminopyrazoles and carried out parallel structural optimization on the benzyl group and the pyrazole ring. This optimization led to a six-fold more potent derivative 32j than the lead compound 1, and this derivative has a 3′,4′-dichloro-(1,1′-biphenyl)-3-yl group.

Copper-catalyzed chlorination of functionalized arylboronic acids

"Chemical Equation Presented" A mild, efficient, Cu(I)-catalyzed method for the conversion of arylboronic acids to aryl chlorides Is reported. This method is particularly useful for the conversion of electron-deficient arylboronic acids to aryl chlorides, a transformation that is inefficient In the absence of Cu catalysis.

Potent non-benzoquinone ansamycin heat shock protein 90 inhibitors from genetic engineering of Streptomyces hygroscopicus

Inhibition of the protein chaperone Hsp90 is a promising new approach to cancer therapy. We describe the preparation of potent non-benzoquinone ansamycins. One of these analogues, generated by feeding 3-amino-5-chlorobenzoic acid to a genetically engineer

Macrolactams by engineered biosynthesis

Macrolactams are made by feeding aromatic amino acids as replacement starter units to a mutant strain of the geldanamycin-producing microorganism Streptomyces hygroscopicus var. geldanus NRRL 3602, wherein the gene cluster encoding enzymes for the biosynt

QUINAZOLINE DERIVATIVES AS ANTIVIRAL AGENTS

The present invention relates to the use of quinazoline derivatives of formula (I) wherein A, B, R1, R2, R3 and R4 are defined herein, and pharmaceutically acceptable salts thereof, for the treatment or preventi